Created in 2012 (United States), ENGINEERING GENETIC CURES own 3 sister brands and 2214 competing brands. The ENGINEERING GENETIC CURES brand is owned by Sangamo BioSciences, a company listed in New York. ENGINEERING GENETIC CURES is part of the Biotechnology activity sector.

ENGINEERING GENETIC CURES is a brand of Sangamo BioSciences (SGMO) Share price

International deposit : 2012 Business sector Biotechnology

Share price and profitability of the share Sangamo BioSciences (ENGINEERING GENETIC CURES)

Buy Sangamo BioSciences share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 0.52

Portfolio valuation
Sangamo BioSciences (ENGINEERING GENETIC CURES) over 5 years* USD 0.02

Stock market history Sangamo BioSciences (ENGINEERING GENETIC CURES)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Sangamo BioSciences

TXCELL
TXCELL
SANGAMO
SANGAMO
See more brands of Sangamo BioSciences

Rival brands
ENGINEERING GENETIC CURES

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS